Metformin reduces vascular endothelial dysfunction caused by an acute glucose load in patients with hypertension

Blood Pressure

Volumn 22, Issue 2, 2013, Pages 106-113

  Zhang, Ting Xing ^a   Xu, Jun Xia ^a   Peng, Feng ^a   Chai, Da Jun ^a   Lin, Jin Xiu ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Acute glucose load; Endothelium dependent vasodilatation; Metformin; Primary hypertension

Indexed keywords

ANTIOXIDANT; FATTY ACID; FREE RADICAL; GLUCOSE; METFORMIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTERY BLOOD FLOW; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED VASODILATATION; HUMAN; HYPERTENSION; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIMARY HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; VASODILATATION;

ADULT; ANTIOXIDANTS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; SUPEROXIDE DISMUTASE; VASODILATION;

EID: 84875160216     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.732761     Document Type: Article

References (38)

1. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340: 1111-1115.
2. Funada J, Sekiya M, Hamada M, Hiwada K. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction . Circ J. 2002; 66: 127-132.
3. van Oostrom AJ, Cabezas MC, Rabelink TJ. Insulin resistance and vessel endothelial function. JR Soc Med. 2002; 95 Suppl 42: 54-61.
4. Parks EJ. Recent fi ndings in the study of postprandial lipemia. Curr Atheroscler Rep. 2001; 3: 462-470.
5. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV. Clinical relevance of postprandial lipaemia. Curr Med Chem. 2005; 12: 1931-1945.
6. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between adiet with ahigh glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002; 75: 492-498.
7. Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, et al. Aprospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am JClin Nutr. 2000; 71: 1455-1461.
8. Mursu J, Virtanen JK, Rissanen TH, Tuomainen TP, Nykanen I, Laukkanen JA, et al. Glycemic index, glycemic load, and the risk of acute myocardial infarction in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Nutr Metab Cardiovasc Dis. 2011; 21: 144-149.
9. Levitan EB, Mittleman MA, Hakansson N, Wolk A. Dietary glycemic index, dietary glycemic load, and cardiovascular disease in middle-aged and older Swedish men. Am J Clin Nutr. 2007; 85: 1521-1526.
10. Wilmink HW, Twickler MB, Banga JD, Dallinga-Thie GM, Eeltink H, Erkelens DW, et al. Effect of statin versus fi brate on postprandial endothelial dysfunction: Role of remnant-like particles. Cardiovasc Res. 2001; 50: 577-582.
11. Vogel RA, Corretti MC, Plotnick GD. Effect of asingle high-fat meal on endothelial function in healthy subjects. Am JCardiol. 1997; 79: 350-354.
12. Lee IK, Kim HS, Bae JH. Endothelial dysfunction: Its relation ship with acute hyperglycaemia and hyperlipidemia. Int JClin Pract Suppl. 2002;(129): 59-64.
13. Tesfamariam B, DeFelice AF. Endothelial injury in the initiation and progression of vascular disorders. Vascul Pharmacol. 2007; 46: 229-237.
14. Gallo A, Ceolotto G, Pinton P, Iori E, Murphy E, Rutter GA, et al. Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes. 2005; 54: 1123-1131.
15. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: An update. Ann Intern Med. 2002; 137: 25-33.
16. Detaille D, Guigas B, Chauvin C, Batandier C, Fontaine E, Wiernsperger N, et al. Metformin prevents high-glucose-induced endothelial cell death through amitochondrial permeability transition-dependent process. Diabetes. 2005; 54: 2179-2187.
17. Hou X, Song J, Li XN, Zhang L, Wang X, Chen L, et al. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun. 2010; 396: 199-205.
18. Guigas B, Detaille D, Chauvin C, Batandier C, De Oliveira F, Fontaine E, et al. Metformin inhibits mitochondrial permeability transition and cell death: Apharmacological in vitro study. Biochem J. 2004; 382(Pt 3): 877-884.
19. Hypertension CF, Rocgfpato PW. Chinese guidelines for prevention and treatment of patients with hypertension. Chinese JHypertension. 2005; 134: 39.
20. Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound. Am JPhysiol. 1995; 268(4 Pt 2): H1397-H1404.
21. Verma S, Bhanot S, Yao L, McNeill JH. Defective endotheliumdependent relaxation in fructose-hypertensive rats. Am JHypertens. 1996; 9(4 Pt 1): 370-376.
22. Verma S, Bhanot S, McNeill JH. Decreased vascular reactivity in metformin-treated fructose-hypertensive rats. Metabolism. 1996; 45: 1053-1055.
23. Verma S, Bhanot S, McNeill JH. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. JPharmacol Exp Ther. 1994; 271: 1334-1337.
24. Verma S, Bhanot S, McNeill JH. Metformin decreases plasma insulin levels and systolic blood pressure in spontaneously hypertensive rats. Am JPhysiol. 1994; 267(4 Pt 2): H1250-H1253.
25. Gokce N, Holbrook M, Duffy SJ, Demissie S, Cupples LA, Biegelsen E, et al. Effects of race and hypertension on fl ow-mediated and nitroglycerin- mediated dilation of the brachial artery. Hypertension. 2001; 38: 1349-1354.
26. Rubira MC, Consolim-Colombo FM, Rabelo ER, Yugar-Toledo JC, Casarini D, Coimbra SR, et al. Venous or arterial endothelium evaluation for early cardiovascular dysfunction in hypertensive patients? JClin Hypertens (Greenwich). 2007; 9: 859-865.
27. Dengel DR, Kelly AS, Steinberger J, Sinaiko AR. Effect of oral glucose loading on endothelial function in normalweight and overweight children. Clin Sci (Lond). 2007; 112: 493-498.
28. Lorbeer R, Empen K, Dorr M, Arndt M, Schipf S, Nauck M, et al. Association between glycosylated haemoglobin A(1c) and endothelial function in an adult non-diabetic population. Atherosclerosis. 2011; 217: 358-363.
29. Horio T, Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Yoshimasa Y, et al. Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension. Am JHypertens. 2005; 18(12 Pt 1): 1626-1630.
30. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes. 2006; 55: 120-127.
31. Orio F, Jr., Palomba S, Cascella T, De Simone B, Manguso F, Savastano S, et al. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study. JClin Endocrinol Metab. 2005; 90: 6072-6076.
32. Naka KK, Kalantaridou SN, Kravariti M, Bechlioulis A, Kazakos N, Calis KA, et al. Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: Aprospective randomized study. Fertil Steril. 2011; 95: 203-209.
33. Attia SM, Helal GK, Alhaider AA. Assessment of genomic instability in normal and diabetic rats treated with metformin. Chem Biol Interact. 2009; 180: 296-304.
34. Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA. Metformin attenuates streptozo tocininduced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact. 2011; 192: 233-242.
35. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 2000; 49: 1231-1238.
36. Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. JAm Coll Cardiol. 2001; 37: 1344-1350.
37. Bogachus LD, Turcotte LP. Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. Am J Physiol Cell Physiol. 2010; 299: C1549-C1561.
38. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. JClin Invest. 2001; 108: 1167-1174.